Related Experiment Video

Updated: Jun 26, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
05:42

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head

Published on: January 3, 2020

Laparoscopic management of insulinomas

A Isla1, J D Arbuckle, P B Kekis

  • 1Department of Surgery, Imperial College Healthcare, London, UK. a.isla@imperial.ac.uk

The British Journal of Surgery
|January 23, 2009
PubMed
Summary

Laparoscopic surgery for insulinomas is safe and effective, offering better recovery than open surgery. Intraoperative ultrasound aids in successful tumor resection, even in complex cases.

More Related Videos

Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions03:34

Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions

Published on: February 9, 2024

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...